Yayınlar & Eserler

Yayın Ağı
Makaleler 11
Tümü (11)
SCI-E, SSCI, AHCI (11)
SCI-E, SSCI, AHCI, ESCI (11)
Scopus (11)

1. Ifosfamide and Doxorubicin Combination Chemotherapy for Recurrent Nasopharyngeal Carcinoma Patients

ŞENER DEDE D., AKSOY S., CENGİZ M., Gullu İ. H., Altundag K.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , cilt.13, sa.5, ss.2225-2228, 2012 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

2. Blood ABO groups and risk of breast cancer

ŞENER DEDE D., AKSOY S., DİZDAR Ö., Cerci P., Gullu İ. H., Ozisik Y., et al.
MEDICAL ONCOLOGY , cilt.27, sa.4, ss.1433, 2010 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

3. Serum levels of CEA and CA 15-3 in triple-negative breast cancer at the time of diagnosis

ŞENER DEDE D., ARSLAN Ç., Altundag K.
MEDICAL ONCOLOGY , cilt.27, sa.4, ss.1429, 2010 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

4. Probable sorafenib-induced reversible encephalopathy in a patient with hepatocellular carcinoma

Dogan E., AKSOY S., ARSLAN Ç., ŞENER DEDE D., Altundag K.
MEDICAL ONCOLOGY , cilt.27, sa.4, ss.1436-1437, 2010 (SCI-Expanded, Scopus) identifier identifier identifier

5. Other malignancies in patients with breast cancer: a single institute experience

Dogan E., AKSOY S., DİZDAR Ö., ŞENER DEDE D., ARSLAN Ç., Ozisik Y., et al.
MEDICAL ONCOLOGY , cilt.27, sa.4, ss.1434-1435, 2010 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

6. Clinical and pathological characteristics of breast cancer patients with history of cesarean delivery

Kalan I., Turgut D., AKSOY S., ŞENER DEDE D., DİZDAR Ö., Ozisik Y., et al.
BREAST , cilt.19, sa.1, ss.67-68, 2010 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

7. Chemotherapy in Older Women with Breast Cancer

DİZDAR Ö., ŞENER DEDE D., Altundag K.
NEW ENGLAND JOURNAL OF MEDICINE , cilt.361, sa.10, ss.1023, 2009 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

8. Pure or mixed-type invasive lobular carcinoma?

Bulut N., ŞENER DEDE D., Sari E., Altundag K.
HUMAN PATHOLOGY , cilt.39, sa.7, ss.1121, 2008 (SCI-Expanded, Scopus) identifier identifier identifier

9. Dasatinib may also inhibit c-Kit in triple negative breast cancer cell lines

DİZDAR Ö., ŞENER DEDE D., Bulut N., Altundag K.
BREAST CANCER RESEARCH AND TREATMENT , cilt.107, sa.2, ss.303, 2008 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

10. Aromatase inhibitor-associated arthralgias: Pathogenesis, frequency and management

Altundag K., ŞENER DEDE D., Harputluoglu H., Gullu İ. H.
JOINT BONE SPINE , cilt.74, sa.6, ss.662-663, 2007 (SCI-Expanded, Scopus) identifier identifier identifier

11. Potential molecular targeted therapies in the management of the basal-like subtype of breast cancer

KURT M., Harputluoglu H., ŞENER DEDE D., GÜLLÜ İ. H., Altundag K.
BREAST , cilt.16, sa.2, ss.111-112, 2007 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier
Metrikler

Yayın

11

Yayın (WoS)

11

Yayın (Scopus)

11

Atıf (WoS)

66

H-İndeks (WoS)

5

Atıf (Scopus)

52

H-İndeks (Scopus)

4

Açık Erişim

2
BM Sürdürülebilir Kalkınma Amaçları